Hence profiling of ratios between EphA2, EphA3, EphA4 and EphA5 expression in the same specimen or their interaction with Ephrin B3 would be interesting to further explore in relation to NSCLC patient survival, especially in non-squamous NSCLC cases. Here, EFNB3 is linked to non-small cell lung carcinoma.